Earnings Insights

AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.

How to use these insights

Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.

Himatsingka Seide Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

revenue exposure to below 50% over the next couple of years by expanding in non-U.S. Key concall takeaways from Himatsingka Seide Ltd's Q2 FY26 earnings call…

30 May 2026

Himatsingka Seide Q4 FY25 earnings call: Revenue & Margins | Arthneeti

Q4 FY25

The company is in the final stages of recalibrating its brand portfolio, with approximately INR150 crores of annual revenue impact still to be neutralized. Key…

30 May 2026

Hikal Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

New products, especially in pharma and animal health, have better gross margins (45-50%), leading to higher EBITDA driven by existing asset base and operating…

30 May 2026

Hikal Q1 FY26 earnings call: Revenue & Margins | Arthneeti

Q1 FY26

31 crores focused on debottlenecking, regulatory upgrades, and CDMO capacity augmentation. Key concall takeaways from Hikal Ltd's Q1 FY26 earnings call — and…

30 May 2026

Hester Biosciences Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

The company discussed ongoing capital expenditure (capex) investments, including capitalization of their fill/finish facility and INR182 crores capital work in…

30 May 2026

Hester Biosciences Q4 FY25 earnings call: Revenue & Margins | Arthneeti

Q4 FY25

Divisional product sales grew 13% despite market headwinds; poultry vaccines and therapeutic products showing steady demand. Key concall takeaways from Hester…

30 May 2026

Hester Biosciences Q3 FY25 earnings call: Revenue & Margins | Arthneeti

Q3 FY25

Capacity utilization: India at ~70% is sufficient for next two years; Africa and Nepal have low utilization but capacity exists for growth. Key concall…

30 May 2026

Gulshan Polyols Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

2,300 crores, driven by optimization and high utilization of existing capacities without new capex. Key concall takeaways from Gulshan Polyols Ltd's Q3 FY26…

30 May 2026

Gulshan Polyols Q3 FY25: Revenue ₹600 Cr | Arthneeti

Q3 FY25

The company has scaled revenue from ₹600 crore to over ₹2,000 crore in 4 years, indicating strong growth. Key concall takeaways from Gulshan Polyols Ltd's Q3…

30 May 2026

GRP Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

Phase 1 capex of INR 150 crores underway, with INR 72 crores spent on green energy business (crumb rubber, tyre pyrolysis, recovered carbon black) and INR 22…

30 May 2026

GRP Q1 FY26 earnings call: Revenue & Margins | Arthneeti

Q1 FY26

125-140 crore revenue post full commercial scale. Key concall takeaways from GRP Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.

30 May 2026

GPT Infraproject Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

As of December 31, 2025, the net unexecuted order book stands at INR 4,415 crores, excluding L1 orders, which is approximately 3.75 times the FY '25 revenues…

30 May 2026

GPT Infraproject Q4 FY25 earnings call: Revenue & Margins | Arthneeti

Q4 FY25

Capacity for Concrete Sleeper segment with all facilities operational is approximately INR 250 crores annually. Key concall takeaways from GPT Infraproject's…

30 May 2026

Geojit Financial Services Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

. Key concall takeaways from Geojit Financial Services's Q2 FY26 earnings call — and how it ranks against sector peers.

30 May 2026

Ganesh Benzoplast Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

Lease rental expenses raised from INR 3 crores to 18-20 crores annually, but compensated by increased pricing and reduced litigation costs. Key concall…

30 May 2026

XT Global Infotech Q1 FY26 earnings call: Revenue & Margins | Arthneeti

Q1 FY26

Consolidated revenue grew 87.2% YoY in Q1 FY26 due to new client wins and higher demand. Key concall takeaways from XT Global Infotech Ltd's Q1 FY26 earnings…

30 May 2026

Foods & Inns Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

Tetra Recart segment currently generates ~INR 2 crores revenue with visibility up to INR 5 crores in FY '26; full capacity utilization could reach INR 80-90…

30 May 2026

Foods & Inns Q3 FY25 earnings call: Revenue & Margins | Arthneeti

Q3 FY25

Some short-term margin impact due to INR 4.2 crores forex MTM loss in recent quarter, but management remains positive overall. Key concall takeaways from Foods…

30 May 2026

Filatex India Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

Capacity expansion planned for later periods (H2 of next financial year), potentially increasing top-line by 10%-12%. Key concall takeaways from Filatex India…

30 May 2026

Everest Kanto Cylinder Q2 FY26: Capex ₹130 Cr | Arthneeti

Q2 FY26

Utilization currently at 70%, with potential to increase up to 80%, indicating room for volume growth. Key concall takeaways from Everest Kanto Cylinder Ltd's…

30 May 2026

Arthneeti Pro · Annual

Every earnings call this season,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access